Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection - eBioMedicine
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection | Nature Medicine
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection | Nature Medicine
Antibody response after first and second BNT162b2 vaccination to predict the need for subsequent injections in nursing home residents | Scientific Reports
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection - eBioMedicine
Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
Anti-Spike protein assays to determine post-vaccination antibody levels: a head-to-head comparison of five quantitative assays | medRxiv
Anti-Spike protein assays to determine post-vaccination antibody levels: a head-to-head comparison of five quantitative assays | medRxiv
WHO standards for COVID-19 established by the ECBS in Dec 2020
Is WHO International Standard for Anti-SARS-CoV-2 Immunoglobulin Clinically Useful?
Clinical Chemistry and Laboratory Medicine (CCLM)
Frontiers | The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients
COVID-19 NAb Test Rapido Quantitativo per il dosaggio degli Anticorpi Neutralizzanti - Bioforniture
Validation and performance of a multiplex serology assay to quantify antibody responses following SARS‐CoV‐2 infection or vaccination - Wilkins - 2022 - Clinical & Translational Immunology - Wiley Online Library
Anti-Spike protein assays to determine post-vaccination antibody levels: a head-to-head comparison of five quantitative assays | medRxiv
Frontiers | The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection - eBioMedicine
Diagnostics | Free Full-Text | Quantitative SARS-CoV-2 Spike Antibody Response in COVID-19 Patients Using Three Fully Automated Immunoassays and a Surrogate Virus Neutralization Test
Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article - ScienceDirect
Is WHO International Standard for Anti-SARS-CoV-2 Immunoglobulin Clinically Useful?
Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
Anticorpi anti SARS-CoV-2 – BioLab
Clinical Chemistry and Laboratory Medicine (CCLM)
Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article - ScienceDirect
COVID-19 NAb Test Rapido Quantitativo per il dosaggio degli Anticorpi Neutralizzanti - Bioforniture
